Document is current
Any future updates will be listed below
-
Authors
Horvath, Steve https://orcid.org/0000-0002-4110-3589
Singh, Kavita
Raj, Ken
Khairnar, Shraddha I.
Sanghavi, Akshay
Shrivastava, Agnivesh
Zoller, Joseph A.
Li, Caesar Z.
Herenu, Claudia B.
Canatelli-Mallat, Martina
Lehmann, Marianne
Habazin, Siniša
Novokmet, Mislav
Vučković, Frano
Solberg Woods, Leah C.
Martinez, Angel Garcia
Wang, Tengfei
Chiavellini, Priscila
Levine, Andrew J.
Chen, Hao
Brooke, Robert T.
Gordevicius, Juozas
Lauc, Gordan
Goya, Rodolfo G.
Katcher, Harold L.
- License Information
-
More Information
Article History
Received: 7 August 2023
Accepted: 9 October 2023
First Online: 24 October 2023
Declarations
:
: Several authors are founders, owners, employees (Harold Katcher and Akshay Sanghavi), or consultants of Yuvan Research (Steve Horvath and Agnivesh Shrivastava) which plans to commercialize the E5 treatment. Other authors (Kavita Singh, Shraddha Khairnar) received financial support from Yuvan Research. Gordan Lauc is a founder and CEO of Genos Ltd., a company specialized in high-throughput glycomics. Siniša Habazin, Mislav Novokmet, and Frano Vučković are employees of Genos Ltd. The other authors do not have conflict of interest.
